MDVL Key Statistics, Chart & Performance
The current stock price of MDVL is 1.8 USD. In the past month the price decreased by -51.22%. In the past year, price decreased by -89%.
MDVL Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| MGRX | MANGOCEUTICALS INC | N/A | 11.34M | ||
| SRXH | SRX HEALTH SOLUTIONS INC | N/A | 5.17M |
Related stock screener links
About MDVL
Company Profile
MedAvail Holdings Inc is a US-based company operating in Consumer Staples Distribution & Retail industry. The company is headquartered in Phoenix, Arizona and currently employs 279 full-time employees. The company went IPO on 2008-10-20. MedAvail Holdings, Inc. is a pharmacy technology and services company. The firm is focused on developing and commercializing a self-service pharmacy, mobile application, and kiosk. Its core technology and product, the MedAvail MedCenter (the MedCenter), is a pharmacist-controlled, patient-interactive, prescription dispensing system akin to a pharmacy in a box. The company operates through two segments: Retail Pharmacy Services and Pharmacy Technology. The Retail Pharmacy Services segment operates as SpotRx, or the Pharmacy, which is a full-service retail pharmacy utilizing its automated pharmacy technology, primarily servicing Medicare patients in the United States. The Pharmacy Technology segment, through its MedAvail Technologies, Inc., develops and commercializes the MedCenter for direct sale or subscription to third-party customers, including some of the healthcare providers and systems, as well as large retail chains that provide full retail-pharmacy services using its technology.
Company Info
MEDAVAIL HOLDINGS INC
4720 E Cotton Gin Loop, Suite 220
Phoenix ARIZONA L5N 5M4 US
CEO: Ed Kilroy
Employees: 279
Phone: 18778300826
MEDAVAIL HOLDINGS INC / MDVL FAQ
What does MDVL do?
MedAvail Holdings Inc is a US-based company operating in Consumer Staples Distribution & Retail industry. The company is headquartered in Phoenix, Arizona and currently employs 279 full-time employees. The company went IPO on 2008-10-20. MedAvail Holdings, Inc. is a pharmacy technology and services company. The firm is focused on developing and commercializing a self-service pharmacy, mobile application, and kiosk. Its core technology and product, the MedAvail MedCenter (the MedCenter), is a pharmacist-controlled, patient-interactive, prescription dispensing system akin to a pharmacy in a box. The company operates through two segments: Retail Pharmacy Services and Pharmacy Technology. The Retail Pharmacy Services segment operates as SpotRx, or the Pharmacy, which is a full-service retail pharmacy utilizing its automated pharmacy technology, primarily servicing Medicare patients in the United States. The Pharmacy Technology segment, through its MedAvail Technologies, Inc., develops and commercializes the MedCenter for direct sale or subscription to third-party customers, including some of the healthcare providers and systems, as well as large retail chains that provide full retail-pharmacy services using its technology.
Can you provide the latest stock price for MEDAVAIL HOLDINGS INC?
The current stock price of MDVL is 1.8 USD. The price decreased by -40.59% in the last trading session.
Does MEDAVAIL HOLDINGS INC pay dividends?
MDVL does not pay a dividend.
How is the ChartMill rating for MEDAVAIL HOLDINGS INC?
MDVL has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
Where is MEDAVAIL HOLDINGS INC (MDVL) stock traded?
MDVL stock is listed on the Nasdaq exchange.
Would investing in MEDAVAIL HOLDINGS INC be a good decision?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on MDVL.
What is the ownership structure of MEDAVAIL HOLDINGS INC (MDVL)?
You can find the ownership structure of MEDAVAIL HOLDINGS INC (MDVL) on the Ownership tab.
MDVL Technical Analysis
MDVL Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to MDVL. MDVL scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
MDVL Financial Highlights
Over the last trailing twelve months MDVL reported a non-GAAP Earnings per Share(EPS) of -43. The EPS decreased by -115.54% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -153.79% | ||
| ROE | -199.57% | ||
| Debt/Equity | 0.07 |
MDVL Forecast & Estimates
7 analysts have analysed MDVL and the average price target is 4.08 USD. This implies a price increase of 126.67% is expected in the next year compared to the current price of 1.8.
For the next year, analysts expect an EPS growth of 99.29% and a revenue growth -92.96% for MDVL